Showing 1 posts of 16 posts found.
Bayer and Onyx Pharmaceutical’s oncology drug Nexavar has failed to meet its primary endpoint in a phase III study for …
Scots neonatal innovations target hearing loss and earlier care
FDA grants De Novo authorisation to light-filtering device for migraine
Southgate opens Innovation Lab for logistics and fulfilment development
Bioptimus partners with Cancer Research Horizons to expand AI cancer data set
Agentis Health Group acquires Clinical Pharmacist Solutions